ALLISON FAWVER: Open Payments
NPI 1811440357 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$570 in 35 payments from 12 companies in 2025. Trend: 2023 $621 · 2024 $536 · 2025 $570
Food & beverage: $570
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $158 |
| AstraZeneca Pharmaceuticals LP | 5 | $84 |
| GlaxoSmithKline, LLC. | 4 | $65 |
| Lilly USA, LLC | 4 | $64 |
| SANOFI-AVENTIS U.S. LLC | 3 | $62 |
| ABBVIE INC. | 2 | $30 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
Products named: Ozempic, BREZTRI, SHINGRIX, MOUNJARO, TZIELD, Wegovy, Rybelsus, UBRELVY.
Industry payments across TN — which companies pay providers there.
